397 results on '"Nakanishi, Mahito"'
Search Results
2. Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors
3. iPSC-derived hypoimmunogenic tissue resident memory T cells mediate robust anti-tumor activity against cervical cancer
4. Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II
5. Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model
6. An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors
7. LRRC15 expression indicates high level of stemness regulated by TWIST1 in mesenchymal stem cells
8. Induced pluripotent stem cells from homozygous Runx2-deficient mice show poor response to vitamin D during osteoblastic differentiation
9. Corrigendum to “Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II” [Molecular Genetics and Metabolism Reports Vol. 37, December 2023, 101021]
10. Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma
11. Induction of Noonan syndrome-specific human-induced pluripotent stem cells under serum-, feeder-, and integration-free conditions
12. Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors
13. Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions
14. Utilization of a novel Sendai virus vector in ex vivo gene therapy for hemophilia A
15. Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells
16. A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy
17. Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors
18. Data from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
19. Supplementary Figure and Table from iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
20. 4-Phenylbutyrate ameliorates apoptotic neural cell death in Down syndrome by reducing protein aggregates
21. Improved secretion of glycoproteins using an N-glycan-restricted passport sequence tag recognized by cargo receptor
22. Generation of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture
23. The Fab portion of immunoglobulin G contributes to its binding to Fcγ receptor III
24. Dual usage of a stage-specific fluorescent reporter system based on a helper-dependent adenoviral vector to visualize osteogenic differentiation
25. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector
26. Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes
27. Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy
28. Biological and Chemical Hybrid Vectors
29. Retrotransposons in Werner syndrome-derived macrophages trigger type I interferon-dependent inflammation in an atherosclerosis model
30. CD81 inhibition with the cytoplasmic RNA vector producing anti-CD81 antibodies suppresses arthritis in a rat CIA model
31. Downregulation of Odd-Skipped Related 2, a Novel Regulator of Epithelial-Mesenchymal Transition, Enables Efficient Somatic Cell Reprogramming
32. LRRC15 Expression Indicates High Level of Stemness Regulated by TWIST1 in Mesenchymal Stem Cells
33. Generation of a control human induced pluripotent stem cell line using the defective and persistent Sendai virus vector system
34. Production of therapeutic iduronate‐2‐sulfatase enzyme with a novel single‐stranded RNA virus vector
35. iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma
36. Entry of Diphtheria Toxin into Cells: Possible Existence of Cellular Factor(s) for Entry of Diphtheria Toxin into Cells Was Studied in Somatic Cell Hybrids and Hybrid Toxins
37. Canine induced pluripotent stem cell maintenance under feeder‐free and chemically‐defined conditions
38. Generation of disease-specific and CRISPR/Cas9-mediated gene-corrected iPS cells from a patient with adult progeria Werner syndrome
39. Development of Defective and Persistent Sendai Virus Vector (SeVdp) and Its Application to Cell Reprogramming: S7-6.
40. Efficient Reprogramming of Canine Peripheral Blood Mononuclear Cells into Induced Pluripotent Stem Cells
41. Regeneration of Tumor-Antigen-Specific Cytotoxic T Lymphocytes from iPSCs Transduced with Exogenous TCR Genes
42. Novel Mucosal Insulin Delivery Systems Based on Fusogenic Liposomes
43. Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity
44. Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers
45. A novel strategy for cancer therapy by mutated mammalian degenerin gene transfer
46. Modeling of Frontotemporal Dementia Using iPSC Technology
47. Generation of Footprint‐Free Canine Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus Vector
48. Pathological manifestation of the induced pluripotent stem cell‐derived cortical neurons from an early‐onset Alzheimer's disease patient carrying a presenilin‐1 mutation (S170F)
49. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells
50. A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.